BillsHH.R. 9421
To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Stage
In committee
Latest action
Referred to the House Committee on Energy and Commerce.
June 24, 2026
Committees
- PrimaryEnergy and Commerce Committee
Action history
- June 24, 2026Introduced in House
- June 24, 2026Introduced in House
- June 24, 2026Referred to the House Committee on Energy and Commerce.